Provided by Tiger Trade Technology Pte. Ltd.

4D Molecular Therapeutics

13.77
+0.14001.03%
Volume:418.18K
Turnover:5.79M
Market Cap:760.71M
PE:-4.99
High:14.20
Open:13.65
Low:13.55
Close:13.63
52wk High:16.93
52wk Low:6.47
Shares:55.24M
Float Shares:42.02M
Volume Ratio:0.71
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.7580
EPS(LYR):-2.4200
ROE:-43.25%
ROA:-25.09%
PB:1.87
PE(LYR):-5.69

Loading ...

Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Aug 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 11, 2023

Major Issues Report

Form 8-K - Current report
Jun 05, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 25, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
May 11, 2023

Major Issues Report

8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 09, 2023

Major Issues Report

8-K - Current report
May 04, 2023

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Apr 21, 2023

Proposed Sale Of Securities

144 - Report of proposed sale of securities
Mar 15, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2023

Major Issues Report

8-K - Current report
Mar 15, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 03, 2023

Major Issues Report

8-K - Current report
Jan 26, 2023

Major Issues Report

8-K - Current report
Nov 09, 2022

Major Issues Report

8-K - Current report